Risk of sudden death and outcome in patients with hypertrophic cardiomyopathy with benign presentation and without risk factors

American Journal of Cardiology

Volumn 113, Issue 9, 2014, Pages 1550-1555

  Spirito, Paolo ^a   Autore, Camillo ^b   Formisano, Francesco ^a   Assenza, Gabriele Egidy ^b   Biagini, Elena ^c   Haas, Tammy S ^d   Bongioanni, Sergio ^e   Semsarian, Christopher ^f   Devoto, Emmanuela ^a   Musumeci, Beatrice ^b   Lai, Francesco ^c   Yeates, Laura ^f   Conte, Maria Rosa ^e   Rapezzi, Claudio ^c   Boni, Luca ^g   Maron, Barry J ^d  

^a GALLIERA HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^e MAURIZIANO HOSPITAL   (Italy)

^f ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^g ISTITUTO TOSCANO TUMORI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIURETIC AGENT;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHILD; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT ATRIAL DIMENSION; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SUDDEN DEATH;

AGED; ANALYSIS OF VARIANCE; ATRIAL FIBRILLATION; CARDIOMYOPATHY, HYPERTROPHIC; DEATH, SUDDEN; DEATH, SUDDEN, CARDIAC; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 84898893552     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2014.01.435     Document Type: Article

References (23)

1. B.J. Maron, W.J. McKenna, G.K. Danielson, L.J. Kappenberger, H.J. Kuhn, C.E. Seidman, P.M. Shah, W.H. Spencer III, P. Spirito, F.J. Ten Cate, and E.D. Wigle American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines J Am Coll Cardiol 42 2003 1687 1713
2. B.J. Gersh, B.J. Maron, R.O. Bonow, J.A. Dearani, M.A. Fifer, M.S. Link, S.S. Naidu, R.A. Nishimura, S.R. Ommen, H. Rakowski, C.E. Seidman, J.A. Towbin, J.E. Udelson, and C.W. Yancy 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 58 2011 e212 e260
3. B.J. Maron, W.K. Shen, M.S. Link, A.E. Epstein, A.K. Almquist, J.P. Daubert, G.H. Bardy, S. Favale, R.F. Rea, G. Boriani, N.A. Estes 3rd, and P. Spirito Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy N Engl J Med 342 2000 365 373
4. B.J. Maron, P. Spirito, W.K. Shen, T.S. Haas, F. Formisano, M.S. Link, A.E. Epstein, A.K. Almquist, J.P. Daubert, T. Lawrenz, G. Boriani, N.A. Estes III, S. Favale, M. Piccininno, S.L. Winters, M. Santini, S. Betocchi, F. Arribas, M.V. Sherrid, G. Buja, C. Semsarian, and P. Bruzzi Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy JAMA 298 2007 405 412
5. P. Spirito, P. Bellone, K.M. Harris, P. Bernabò, P. Bruzzi, and B.J. Maron Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy N Engl J Med 342 2000 1778 1785
6. P.M. Elliott, J. Poloniecki, S. Dickie, S. Sharma, L. Monserrat, A. Varnava, N.G. Mahon, and W.J. McKenna Sudden death in hypertrophic cardiomyopathy: identification of high risk patients J Am Coll Cardiol 36 2000 2212 2218
7. P.M. Elliott, B. Gimeno Jr., N.G. Mahon, J.D. Poloniecki, and W.J. McKenna Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy Lancet 357 2001 420 424
8. P. Spirito, C. Autore, C. Rapezzi, P. Bernabò, R. Badagliacca, M.S. Maron, S. Bongioanni, F. Coccolo, N.A. Mark Estes, C.S. Barillà, E. Biagini, G. Quarta, M.R. Conte, P. Bruzzi, and B.J. Maron Syncope and risk of sudden death in hypertrophic cardiomyopathy Circulation 119 2009 1703 1710
9. B.J. Maron Sudden death in hypertrophic cardiomyopathy. Contemporary insights and strategies for risk stratification and prevention Circulation 121 2010 445 456
10. B.J. Maron, J.M. Gardin, J.M. Flack, S.S. Gidding, T.T. Kurosaki, and D.E. Bild Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4,111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults Circulation 92 1995 785 789
11. B.J. Maron, I. Olivotto, P. Bellone, M.R. Conte, F. Cecchi, B.P. Flygenring, S.A. Casey, T.E. Gohman, S. Bongioanni, and P. Spirito Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy J Am Coll Cardiol 39 2002 301 307
12. B.J. Maron, I. Olivotto, P. Spirito, S.A. Casey, P. Bellone, T.E. Gohman, K.J. Graham, D.A. Burton, and F. Cecchi Epidemiology of hypertrophic cardiomyopathy related death: revisited in a large non-referral-based patient population Circulation 102 2000 858 864
13. P. Spirito, F. Chiarella, L. Carratino, M.Z. Berisso, P. Bellotti, and C. Vecchio Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population N Engl J Med 320 1989 749 755
14. F. Cecchi, I. Olivotto, A. Montereggi, G. Santoro, A. Dolara, and B.J. Maron Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population J Am Coll Cardiol 26 1995 1529 1536
15. C.R. Cannan, G.S. Reeder, K.R. Bailey, L.J. Melton, and B.J. Gersh Natural history of hypertrophic cardiomyopathy: a population-based study, 1976 through 1990 Circulation 92 1995 2488 2495
16. B.J. Maron, S.A. Casey, L.C. Poliac, T.E. Gohman, A.K. Almquist, and D.M. Aeppli Clinical course of hypertrophic cardiomyopathy in a regional United States cohort JAMA 281 1999 650 655
17. A.S. Adabag, B.J. Maron, E. Appelbaum, C.J. Harrigan, J.L. Buros, C.M. Gibson, J.R. Lesser, C.A. Hanna, J.E. Udelson, W.J. Manning, and M.S. Maron Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance J Am Coll Cardiol 51 2008 1369 1374
18. M.S. Maron, E. Appelbaum, C.J. Harrigan, J. Buros, C.M. Gibson, C. Hanna, J.R. Lesser, J.E. Udelson, W.J. Manning, and B.J. Maron Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy Circ Heart Fail 1 2008 184 191
19. R. Rubinshtein, J.F. Glockner, S.R. Ommen, P.A. Araoz, M.J. Ackerman, P. Sorajja, J.M. Bos, A.J. Tajik, U.S. Valeti, R.A. Nishimura, and B.J. Gersh Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy Circ Heart Fail 3 2010 51 58
20. M. Salerno, and C.M. Kramer Prognosis in hypertrophic cardiomyopathy with contrast-enhanced cardiac magnetic resonance: the future looks bright J Am Coll Cardiol 56 2010 888 889
21. M.S. Maron, I. Olivotto, S. Betocchi, S.A. Casey, J.R. Lesser, M.A. Losi, F. Cecchi, and B.J. Maron Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy N Engl J Med 348 2003 295 303
22. C. Autore, P. Bernabò, C.S. Barillà, P. Bruzzi, and P. Spirito The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms J Am Coll Cardiol 45 2005 1076 1080
23. P. Sorajja, R.A. Nishimura, B.J. Gersh, J.A. Dearani, D.O. Hodge, H.J. Wiste, and S.R. Ommen Outcome of mildly symptomatic or asymptomatic obstructive hypertrophic cardiomyopathy: a long-term follow-up study J Am Coll Cardiol 54 2009 234 241